Page last updated: 2024-09-03

cystic fibrosis transmembrane conductance regulator (505-511) and Growth Disorders

cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Growth Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aebischer, CC; Keller, BM; Kraemer, R; Schöni, MH1

Other Studies

1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and Growth Disorders

ArticleYear
Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2003, Volume: 2, Issue:2

    Topics: Adolescent; Analysis of Variance; Body Height; Body Mass Index; Body Weight; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Genotype; Growth Disorders; Homozygote; Hospitals, Pediatric; Humans; Linear Models; Longitudinal Studies; Male; Maximal Midexpiratory Flow Rate; Mutation; Peptide Fragments; Retrospective Studies; Switzerland; Vital Capacity

2003